Karen Babitt, MD
Internal Medicine · Baltimore, MDNPI 1073583787
Payments from drug & device makers
Across 235 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$942
- AbbVie$467
- AstraZeneca$439
- Lilly USA, LLC$367
- Astellas Pharma US Inc$201
- Exact Sciences$198
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,263100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 57 | $942 |
| AbbVie | 25 | $467 |
| AstraZeneca | 24 | $439 |
| Lilly USA, LLC | 21 | $367 |
| Astellas Pharma US Inc | 11 | $201 |
| Exact Sciences | 8 | $198 |
| GSK | 11 | $193 |
| Pfizer | 11 | $176 |
| Amgen(2 entities) | 8 | $173 |
| Merck | 6 | $128 |
| Bayer | 5 | $124 |
| Sanofi-aventis U.S. LLC | 6 | $116 |
| Boehringer Ingelheim | 7 | $110 |
| Johnson & Johnson | 6 | $102 |
| Amarin Pharma, Inc. | 4 | $78 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Hikma Pharmaceuticals USA | 3 | $39 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Novartis | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| UCB, Inc. | 1 | $27 |
| Mannkind Corporation | 2 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Sanofi | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$4,263 in reported general payments places this provider in the 85th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid | 13 | $1,280 |
| Atorvastatin Calcium | 87 | $1,211 |
| Amlodipine Besylate | 121 | $933 |
| Losartan Potassium | 55 | $771 |
| Rosuvastatin Calcium | 54 | $717 |
| Metoprolol Succinate | 37 | $638 |
| Pravastatin Sodium | 39 | $541 |
| Fluticasone Propionate | 17 | $461 |
| Escitalopram Oxalate | 16 | $336 |
| Lisinopril | 34 | $321 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 22 | $304 |
| Levothyroxine Sodium | 26 | $287 |
| Olmesartan Medoxomil | 16 | $279 |
| Potassium Chloride | 11 | $264 |
| Omeprazole | 15 | $263 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Baltimore
- Kristen MarroneBaltimore$5.6M
- Peta-Gay Jackson BoothBaltimore$3.6M
- Mark YarchoanBaltimore$2.4M
- Gabrielle PrinceBaltimore$2.1M
- Jessica TaoBaltimore$1.2M
- Ana-Maria OrbaiBaltimore$1.1M
- Julie PaikBaltimore$1M
- Christopher MelaniBaltimore$997K
- Ethel WeldBaltimore$792K
- Christian GockeBaltimore$725K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.